Tai Qin

425 total citations · 1 hit paper
13 papers, 303 citations indexed

About

Tai Qin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tai Qin has authored 13 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tai Qin's work include Prostate Cancer Treatment and Research (4 papers), Hedgehog Signaling Pathway Studies (2 papers) and Cancer Cells and Metastasis (2 papers). Tai Qin is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Hedgehog Signaling Pathway Studies (2 papers) and Cancer Cells and Metastasis (2 papers). Tai Qin collaborates with scholars based in China, United States and Australia. Tai Qin's co-authors include Lu‐Zhe Sun, Xiuchao Wang, Jihui Hao, He Ren, Song Gao, Yu Xu, Xueqiong Zhu, Roberto J. Fajardo, Jingcheng Liu and Chuntao Gao and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Tai Qin

13 papers receiving 301 citations

Hit Papers

Tislelizumab Plus Platinum and Etoposide Versus Placebo P... 2024 2026 2025 2024 10 20 30 40 50

Peers

Tai Qin
Tai Qin
Citations per year, relative to Tai Qin Tai Qin (= 1×) peers Maria Cristina Villarroel

Countries citing papers authored by Tai Qin

Since Specialization
Citations

This map shows the geographic impact of Tai Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tai Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tai Qin more than expected).

Fields of papers citing papers by Tai Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tai Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tai Qin. The network helps show where Tai Qin may publish in the future.

Co-authorship network of co-authors of Tai Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Tai Qin. A scholar is included among the top collaborators of Tai Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tai Qin. Tai Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tine, Brian A. Van, Sophie Postel‐Vinay, Hui Gan, et al.. (2025). Abstract CT193: Trial in progress: A first-in-human phase 1a/b study of BGB-58067, an MTA-cooperative PRMT5 inhibitor, in patients with advanced solid tumors and MTAP deficiency. Cancer Research. 85(8_Supplement_2). CT193–CT193. 1 indexed citations
2.
Cheng, Ying, Yun Fan, Yanqiu Zhao, et al.. (2024). Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial. Journal of Thoracic Oncology. 19(7). 1073–1085. 56 indexed citations breakdown →
3.
Deng, Janice, Tai Qin, Yuqian Yan, et al.. (2021). GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer. Molecular Cancer Research. 20(1). 62–76. 17 indexed citations
4.
Xia, Lu, Hakim Bouamar, Xiang Gu, et al.. (2020). Gli2 mediates the development of castration‑resistant prostate cancer. International Journal of Oncology. 57(1). 100–112. 13 indexed citations
5.
Huang, Yumeng, et al.. (2019). The Structural Integrity of Plasmid-Encoded Pgp3 Is Essential for Induction of Hydrosalpinx by Chlamydia muridarum. Frontiers in Cellular and Infection Microbiology. 9. 13–13. 8 indexed citations
6.
Liu, Jing, Wenna Jiang, Kaili Zhao, et al.. (2019). Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. The Journal of Experimental Medicine. 216(3). 656–673. 34 indexed citations
7.
Hu, Jinmeng, Tai Qin, Song Gao, et al.. (2018). Pancreaticoduodenectomy: a single center experience of 118 patients. Zhonghua gan-dan waike zazhi. 24(8). 542–544. 1 indexed citations
8.
Li, Jian, Weidong Ma, Song Gao, et al.. (2018). The expression of PTK7 in pancreatic ductal adenocarcinoma and its clinical significance. Clinical Oncology and Cancer Research. 45(20). 1038–1043. 1 indexed citations
9.
Wang, Xiuchao, Jie Dong, Li Jia, et al.. (2017). HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Cancer Letters. 393. 113–124. 35 indexed citations
10.
Xu, Yu, Tai Qin, Jing Li, et al.. (2017). Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. International Journal of Molecular Sciences. 18(4). 622–622. 51 indexed citations
11.
Qin, Tai, Lu Xia, Haojie Huang, et al.. (2016). A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands. Oncotarget. 7(52). 86087–86102. 33 indexed citations
12.
Qin, Tai, James E. Schmitz, Roberto J. Fajardo, et al.. (2015). Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer. Oncotarget. 6(42). 44388–44402. 50 indexed citations
13.
Zhang, Yu, Tai Qin, N. Noda, & Meng Duan. (2013). Strength analysis of adhesive joints of riser pipes in deep sea environment loadings. 1(1). 9–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026